MedTrace Logo

Vitamin C for the Prevention of UTI in Women Who Undergo Elective GYN Surgeries

NCT03800667 · Status: WITHDRAWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL

Last updated 2019-07-15

No results posted yet for this study

Summary

This open-label randomized trial aims at assessing the role of Vitamin C pills in the prevention of catheter-associated urinary tract infections in women undergoing elective gynecological surgeries.

Conditions

  • Catheter-Associated Urinary Tract Infection, Ascorbic Acid

Interventions

DRUG

Ascorbic Acid 1000 MG

1000 mg ascorbic acid (Vitamin C) for 1 month post-op after an elective gynecological surgery.

Sponsors & Collaborators

  • American University of Beirut Medical Center

    lead OTHER

Principal Investigators

  • Tony Bazi, MD · American University of Beirut Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-08
Primary Completion
2019-07-12
Completion
2019-07-12
FDA Drug
Yes

Countries

  • Lebanon

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03800667 on ClinicalTrials.gov